NO924949L - Piperidylsubstituerte indoler - Google Patents

Piperidylsubstituerte indoler

Info

Publication number
NO924949L
NO924949L NO92924949A NO924949A NO924949L NO 924949 L NO924949 L NO 924949L NO 92924949 A NO92924949 A NO 92924949A NO 924949 A NO924949 A NO 924949A NO 924949 L NO924949 L NO 924949L
Authority
NO
Norway
Prior art keywords
piperidyl
methyl
indols
substituted
substituted indols
Prior art date
Application number
NO92924949A
Other languages
English (en)
Norwegian (no)
Other versions
NO924949D0 (no
Inventor
Jens Kristian Perregaard
Brenda Costall
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO924949D0 publication Critical patent/NO924949D0/no
Publication of NO924949L publication Critical patent/NO924949L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO92924949A 1990-06-22 1992-12-21 Piperidylsubstituerte indoler NO924949L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK152090A DK152090D0 (da) 1990-06-22 1990-06-22 Piperidylsubstituerede indolderivater
PCT/DK1991/000168 WO1992000070A1 (en) 1990-06-22 1991-06-21 Piperidyl-substituted indoles
SG19795A SG19795G (en) 1990-06-22 1995-02-07 Piperidyl-substituted indoles

Publications (2)

Publication Number Publication Date
NO924949D0 NO924949D0 (no) 1992-12-21
NO924949L true NO924949L (no) 1993-02-19

Family

ID=26065861

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924949A NO924949L (no) 1990-06-22 1992-12-21 Piperidylsubstituerte indoler

Country Status (17)

Country Link
US (1) US5439922A (ja)
EP (1) EP0533824B1 (ja)
JP (1) JP3332232B2 (ja)
AT (1) ATE113838T1 (ja)
AU (1) AU650464B2 (ja)
CA (1) CA2085987C (ja)
DE (1) DE69105135T2 (ja)
DK (2) DK152090D0 (ja)
FI (1) FI925801A (ja)
HK (1) HK51395A (ja)
IE (1) IE65421B1 (ja)
IL (1) IL98574A (ja)
NO (1) NO924949L (ja)
NZ (1) NZ238655A (ja)
SG (1) SG19795G (ja)
WO (1) WO1992000070A1 (ja)
ZA (1) ZA914747B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK55192D0 (da) * 1992-04-28 1992-04-28 Lundbeck & Co As H 1-piperazino-1,2-dihydroindenderivater
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
DK148292D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Forbindelser
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
DK123493D0 (da) * 1993-11-01 1993-11-01 Lundbeck & Co As H Compounds
DK139593D0 (da) * 1993-12-16 1993-12-16 Lundbeck & Co As H Compounds
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
GB9523583D0 (en) * 1995-11-17 1996-01-17 Merck Sharp & Dohme Therapeutic agents
DE19707628A1 (de) * 1997-02-26 1998-08-27 Merck Patent Gmbh Oxazolidinone
US6489341B1 (en) * 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
US20070212412A1 (en) * 2005-09-08 2007-09-13 H. Lundbeck A/S Stable solid formulation of sertindole
TW200821296A (en) * 2006-06-01 2008-05-16 Lundbeck & Co As H Use of sertindole for the preventive treatment of suicidal behaviour

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258843B1 (ja) * 1974-01-30 1977-09-09 Roussel Uclaf
US4208417A (en) * 1978-06-29 1980-06-17 Pharmindustrie Indole derivatives and their use as anxiolytics
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4997841A (en) * 1987-08-13 1991-03-05 Glaxo Group Limited Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater

Also Published As

Publication number Publication date
DE69105135D1 (de) 1994-12-15
ZA914747B (en) 1992-03-25
EP0533824B1 (en) 1994-11-09
FI925801A0 (fi) 1992-12-21
IL98574A0 (en) 1992-07-15
NZ238655A (en) 1993-11-25
DK152090D0 (da) 1990-06-22
NO924949D0 (no) 1992-12-21
CA2085987A1 (en) 1991-12-23
AU8068491A (en) 1992-01-23
CA2085987C (en) 2000-08-22
ATE113838T1 (de) 1994-11-15
JPH05509080A (ja) 1993-12-16
HK51395A (en) 1995-04-13
DK0533824T3 (da) 1995-05-01
DE69105135T2 (de) 1995-03-23
AU650464B2 (en) 1994-06-23
SG19795G (en) 1995-08-18
WO1992000070A1 (en) 1992-01-09
US5439922A (en) 1995-08-08
IE65421B1 (en) 1995-10-18
EP0533824A1 (en) 1993-03-31
JP3332232B2 (ja) 2002-10-07
FI925801A (fi) 1992-12-21
IE912137A1 (en) 1992-01-01
IL98574A (en) 1995-11-27

Similar Documents

Publication Publication Date Title
NO924949L (no) Piperidylsubstituerte indoler
DK0646115T3 (da) Heterocykliske/cykliske aminderivater
BG61321B1 (bg) (1н-имидазол-1-илметил) заместени бензимидазолови производни
RU93005057A (ru) Фармацевтические соединения, производные тиенобензодиазепина, способ их получения, фармкомпозиция и их использование
ATE224T1 (de) 1,2-dihydro-chinolin-2-on-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
FI863488A0 (fi) Foereningar.
SE7811455L (sv) 2-imino-imidazolidin-derivat
YU140391A (sh) 6-supstituisani-heksahidrobenz (cd)-indoli
DK601888D0 (da) Anvendelse af 2-pyrimidinyl-1-piperazinderivater
DE59206593D1 (de) Verwendung von 2-Iminothiazolidin-4-onderivaten als neuartige Arzneimittelwirkstoffe
GR82222B (ja)
SE8302452D0 (sv) Method for treatment of senile dementia
EP0116255A3 (en) Treatment of migraine with n-alkyl-piperidinyl benzoate derivatives
ATE31925T1 (de) 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide.
FI944076A (fi) Menetelmä terapeuttisesti käytt¦kelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
TR199701185A2 (xx) Sefalosporin piridinyum t�revleri.
FI935399A (fi) N-substituerade azabicykloheptanderivat samt deras framstaellning och anvaendning
ES2111760T3 (es) Utilizacion de cetogluconatos en fotografia.